| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.13 | 0.7 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.062 | 0.7 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |